What I have: a GLP-1 receptor agonist · 0.9% sodium chloride.
I suspect the usual explanation for this is wrong, or at least incomplete.
I am aware this may have a boring answer. I would still like the boring answer stated clearly.
Can someone derive this rather than assert it?
The underlying point is that add the diluent down the vial wall rather than directly onto the cake. Peptides are surface-active and shear at an air–liquid interface, so a jet of water into a lyophilised puck generates foam, and foam is aggregated protein at the interface, not just air.
Tilting the vial to pool solution in the corner before the final draw, and giving it a minute to drain down the walls, genuinely recovers ten to twenty microlitres.
Do not use the same needle to pierce the stopper and to administer.
Published data on syringe dead space in the context of injection-equipment programmes quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more.
The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.
edited 18 Jul 2026 by tandem_gradient — added the placebo-arm figures
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemTo be exact about it, read the cake before you touch the vial. An intact, opaque, evenly distributed puck that sits proud of the vial base is what a good lyophilisation cycle produces. Anything else — collapse, melt-back at the stopper, a glassy film, a cake that has slumped to one side — is evidence about the cycle, the shipping, or both.
The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing.
Specifically, a 0.22 µm syringe filter will remove particulates and organisms, and it will also adsorb a fraction of your peptide.
The caveat is that this is not a recommendation to administer anything. Research-use-only material is not approved for human use.
None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.
Mechanically, gentle swirling dissolves a lyophilised cake far better than vigorous shaking, which causes aeration and aggregation.
Photograph the vial against a matte black card with a single point light source off to one side, not with a flash from the front.
On the detail: number of stopper piercings matters less than the gauge doing the piercing.
The 28-day beyond-use convention for a multiple-withdrawal preserved preparation derives from USP compounding chapters, which set it on microbiological risk rather than chemical stability.
Do the arithmetic twice, ideally with someone else doing it independently.
Reconstitution is the step where most hands-on errors enter the system, which is why spending time on technique here pays off more than anywhere else.
The order of operations matters: temperature first, then diluent measurement, then injection, then gentle dissolution, then labeling.
The general principle — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science.
One limitation: technique reduces risk, it does not remove it.
The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.